混合型高脂血症

结论阿托伐他汀10mgd治疗混合型高脂血症可以明显降低TC、LDLc，TG和（TCHDLC）HDLc；

Conclusions Atorvastatin 10 mg / d can significantly lower TC , LDL C , TG and ( TC HDL C ) / HDL C in combined dyslipidemia .

洛伐他汀与Omega-3脂肪酸对老年混合型高脂血症患者的影响

The efficacy of lovastatin and omega-3 fatty acid in treatment of combined hyperlipidemia in old people

目的家族性混合型高脂血症（FCHL）是最常见的血脂代谢异常，在心肌梗死幸存者中的比例为10%～20%，本研究旨在探讨FCHL患者与载脂蛋白E基因多态性的关系。

Objective Familial combined hyperlipidemia ( FCHL ) is the most common hyperlipidemic disorder with a frequency of 10 % ~ 20 % in myocardial infarction survivors . The present study is to investigate the relation between FCHL and apoE polymorphism .

家族性混合型高脂血症的发病机理及转基因动物研究进展

Advances in Pathogenesis of Familial Combind Hyperlipidemia and Transgenic Animal Model

阿托伐他汀、非诺贝特、降脂通络软胶囊对混合型高脂血症患者血脂水平及肝功能的影响

The Influence of Statins Capsule for the Treatment of Combined Hyperlipidemia

阿托伐他汀对混合型高脂血症患者血管内皮依赖性舒张功能的影响

Effect of Atorvastatin on Endothelium-Dependent Diastolic Function of Patients with Mixed Hyperlipemia

混合型高脂血症患者血小板活性和纤溶活性的变化

Changes of Platelet Activity and Fibrinolytic Activty in Patients with Combined Hyperlipidemia

阿昔莫司对老年糖尿病患者混合型高脂血症的影响

Effect of acipimox for treating combined hyperlipidemia in the elderly patients with diabetes

家族性混合型高脂血症与脂蛋白脂酶基因的连锁分析

Linkage analysis between familial combined hyperlipidemia and lipoprotein lipase gene in Chinese families

依泽替米贝和非诺贝特联合治疗混合型高脂血症患者的有效性和安全性

Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia

混合型高脂血症治疗新见识

New Insights in Treatment of Combined Hyperlipidemia

氟伐他汀与非诺贝特联合和大剂量氟伐他汀强化治疗混合型高脂血症的临床观察

Fluvastatin and fenofibrate and fluvastatin of high dosage in management of hyperlipidemia familial combined hyperlipidemia

阿昔莫司联合氟伐他汀治疗老年混合型高脂血症的疗效和安全性研究

Curative Effects and Safety Study of Acipimox Combined with Fluvastatin Treating the Aged with Mixed Hyperlipemia

目的：探讨混合型高脂血症与肝脂酶基因启动子250G/A多态性的关系。

Objective To study the interaction between hepatic lipase gene-250G / A polymorphism and combined hyperlipidemia .

阿托伐他汀与常用调脂药物治疗老年混合型高脂血症的疗效比较分析

Efficacy comparison of atorvastatin , simvastatin , lovastatin + polyunsaturated fatty acid in treatment on aged people with combined hyperlipidaemia

目的评价洛伐他汀单用及与Omega3脂肪酸联合治疗老年混合型高脂血症患者的疗效与安全性。

Objective To evaluate the efficacy and safety of lovastatin and lovastatin + omega 3 fatty acid in treatment of combined hyperlipidemia in old people .